-
Vietnam and EU upgrade ties as EU chief visits Hanoi
-
Senegal coach Thiaw gets five-match ban after AFCON final chaos
-
Phan Huy: the fashion prodigy putting Vietnam on the map
-
Hongkongers snap up silver as gold becomes 'too expensive'
-
Britain's Starmer meets China's Xi for talks on trade, security
-
Chinese quadriplegic runs farm with just one finger
-
Gold soars past $5,500 as Trump sabre rattles over Iran
-
China's ambassador warns Australia on buyback of key port
-
'Bombshell': What top general's fall means for China's military
-
As US tensions churn, new generation of protest singers meet the moment
-
Venezuelans eye economic revival with hoped-for oil resurgence
-
Online platforms offer filtering to fight AI slop
-
With Trump allies watching, Canada oil hub faces separatist bid
-
Samsung Electronics posts record profit on AI demand
-
Strategic Friction: Turning Diversity into a Competitive Moat
-
Rockets veteran Adams out for rest of NBA season
-
Holders PSG happy to take 'long route' via Champions League play-offs
-
French Senate adopts bill to return colonial-era art
-
Allrounder Molineux named Australian women's cricket captain
-
Sabalenka faces Svitolina roadblock in Melbourne final quest
-
Tesla profits tumble on lower EV sales, AI spending surge
-
Joao Pedro fires Chelsea into Champions League last 16, dumps out Napoli
-
LA mayor urges US to reassure visiting World Cup fans
-
Madrid condemned to Champions League play-off after Benfica loss
-
Meta shares jump on strong earnings report
-
Haaland ends barren run as Man City reach Champions League last 16
-
PSG and Newcastle drop into Champions League play-offs after stalemate
-
Salah ends drought as Liverpool hit Qarabag for six to reach Champions League last 16
-
Barca rout Copenhagen to reach Champions League last 16
-
Arsenal complete Champions League clean sweep for top spot
-
Kolo Muani and Solanke send Spurs into Champions League last 16
-
Bayern inflict Kane-ful Champions League defeat on PSV
-
Pedro double fires Chelsea into Champions League last 16, dumps out Napoli
-
US capital Washington under fire after massive sewage leak
-
Anti-immigration protesters force climbdown in Sundance documentary
-
US ambassador says no ICE patrols at Winter Olympics
-
Norway's Kristoffersen wins Schladming slalom
-
Springsteen releases fiery ode to Minneapolis shooting victims
-
Brady latest to blast Belichick Hall of Fame snub
-
Trump battles Minneapolis shooting fallout as agents put on leave
-
SpaceX eyes IPO timed to planet alignment and Musk birthday: report
-
White House, Slovakia deny report on Trump's mental state
-
Iran vows to resist any US attack, insists ready for nuclear deal
-
Colombia leader offers talks to end trade war with Ecuador
-
Former Masters champ Reed returning to PGA Tour from LIV
-
Norway's McGrath tops first leg of Schladming slalom
-
Iraq PM candidate Maliki denounces Trump's 'blatant' interference
-
Neil Young gifts music to Greenland residents for stress relief
-
Rubio upbeat on Venezuela cooperation but wields stick
-
'No. 1 fan': Rapper Minaj backs Trump
Featured
Last news
David's Bridal Launches 'David's Style Squad' Ambassador Program to Scale Creator-Led Commerce and Community Advocacy
New Initiative Expands the Brand's 'Aisle to Algorithm' Ecosystem, Blending Employee Advocates, Influencers, and Everyday Creators Into a Performance-Driven Social Commerce Engine
Cellev8 Nutrition Welcomes Dr. Guangshuo "Alan" Zhu, MD to Its Board of Directors
WELLINGTON, FLORIDA / ACCESS Newswire / January 8, 2026 / Cellev8 Nutrition Inc., (OTCID:CELV) a leader in clinically validated antioxidant and cellular nutrition solutions, proudly announces the appointment of Dr. Guangshuo "Alan" Zhu, MD to its Board of Directors. Dr. Zhu brings decades of groundbreaking experience in cardiovascular medicine, translational research, and antioxidant biochemistry, including pioneering work in Superoxide Dismutase (SOD) - a core ingredient and biological inspiration behind Cellev8's advanced cellular protection technologies.
Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines
Conference Call to be Hosted on Monday, January 12 at 1:30 PM PT/4:30 PM ET
Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection
~ New ADHD pipeline leverages TAAP™ and MPAR® technologies to improve safety for patients ~
Kidoz Inc. Presenting at the 3rd Annual DealFlow Discovery Conference
ATLANTIC CITY, NJ / ACCESS Newswire / January 8, 2026 / Kidoz Inc. (TSXV:KDOZ)(OTCQB:KDOZF) (the "Company"), a global AdTech platform delivering safe mobile gamer engagement at scale, today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026.
Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy
Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice President of Global Business DevelopmentAppointments underscore Ascend-ABL's commitment to scientific rigor, operational excellence, and strategic growth
FDA Clears Toetal Solution's Ziptoe Hammertoe System
Company Positioned for Strategic Transaction
New Digital Platform Fast Food Menu info Launches to Simplify Fast-Food Menu and Pricing Decisions
Deciding what to eat just got easier, particularly in the USA. Today marks the official launch of Fast Food Menu info, a comprehensive digital platform designed to provide consumers with instant access to up-to-date menus, pricing, and nutritional information for the nation's most popular fast-food chains.
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
Just - Evotec Biologics will optimize monoclonal antibodies ("mAbs") and other biologic modalitiesInvestment enables ten new J.MD™ projects encompassing molecular optimization including, but not limited to: improved titer, pharmacokinetics, immunogenicity, and stability, over the next three years
Lighthouse Names Georg Beyschlag Chief Financial Officer as Company Scales for Next Phase of Global Growth
Current CFO Matthias Geeroms transitions to Head of Corporate Development
US immigration officer fatally shoots woman in Minneapolis
An immigration agent in Minneapolis shot dead a woman Wednesday, triggering outrage from local leaders even as President Donald Trump claimed the officer acted in self-defense.
3,000 tourists evacuated as Argentine Patagonia battles wildfires
Argentine authorities have evacuated some 3,000 tourists from a sparsely populated Patagonian district ravaged by wildfires for days, officials said Wednesday.
Arraignment postponed for Rob Reiner's son over parents' murder
An arraignment for the son of Hollywood director Rob Reiner over the stabbing deaths of his parents was postponed Wednesday, after his lawyer stepped back from the case.
Accused scam boss Chen Zhi arrested in Cambodia, extradited to China: Phnom Penh
Chinese-born tycoon Chen Zhi, who was indicted by the United States on fraud and money-laundering charges for running a multibillion-dollar cyberscam network from Cambodia, has been arrested there and extradited to China, Phnom Penh said Wednesday.
Frenchwoman accused of libel over Nazi 'collaborator' family novel
A historian of the Nazi occupation of France was being sued Wednesday by her own relatives for alleged libel after she promoted her first novel as inspired by her family's history.
UN accuses Israel of West Bank 'apartheid'
The United Nations on Wednesday said decades-long discrimination and segregation of Palestinians by Israel in the West Bank were intensifying, and called on the country to end its "apartheid system".
Vietnamese caught in Japan's illegal worker crackdown
For a decade, Vietnamese worker Minh did tough jobs like sandblasting ships and welding steel, helping address rapidly ageing Japan's dire labour needs.
Obituary Notice: Peter Schlesinger, 19-Time Emmy Award-Winning Television Producer and Longtime KCOP-TV Program Director
LOS ANGELES, CA / ACCESS Newswire / January 7, 2026 / It is with great sadness that we announce the passing of Peter Schlesinger, a noted figure in the television industry who served as Program Director for KCOP-TV from 1971 to 2001 and as a multiple Emmy Award-winning Executive Producer for both national and local television programming. Peter passed away on December 5 in Calabasas.
Emerging Growth Research Maintains Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Strategic U.S. Market Entry
NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Emerging Growth Research today announced the release of its Flash Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), maintaining a Buy-Extended rating and its 12-month price target of $9.00, representing significant upside from the Company's closing price of $4.44 on January 6, 2026.
A Suitcase Full of Stories: Bring Home More Than Just Memories - Take Home Culture Too
Saudia Turns Luggage into Cultural Storytelling with ‘Let It Fly' Initiative
TRNR Provides Shareholder Update on Sportstech Process & Operating Strategy
AUSTIN, TEXAS / ACCESS Newswire / January 7, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, today announced that it has published a shareholder letter updating investors with respect to the Sportstech loan and acquisition process and providing additional context about its improved operating scale and near-term plans.
AMEEREX Enters Strategic Partnership With Patagonia Lithium (ASX: PL3), Gaining Exposure to Inferred and Indicated 551,000 tonnes of Lithium Carbonate Equivalent JORC-Validated Lithium Resource by WSP Australia
ATLANTA, GA / ACCESS Newswire / January 7, 2026 / AMEEREX Corporation ("Ameerex" or the "Company") today announced that it has entered into a strategic partnership with Patagonia Lithium Limited (ASX:PL3), working towards securing a material economic interest in a world-class lithium brine resource located in Argentina's Lithium Triangle, one of the most important lithium-producing regions globally.
EDGE Surgical Launches Universal Depth Gauge - A Breakthrough in Orthopedics
BURLINGTON, MA / ACCESS Newswire / January 7, 2026 / EDGE Surgical, Inc, the innovative brand behind the world's only electronic depth gauge for orthopedic surgery, today announced the launch of a Universal Depth Gauge compatible with all major orthopedic plating systems. With patent-pending dynamic calibration technology, the Ortho EDG® is the world's first depth gauge to work with every major plating system - a quantum leap forward in depth gauge technology.
Medical Care Technologies' Infinite Auctions to Offer Original Art by Iconic Artist Rob Prior Signed by Stan Lee, Chris Evans, Al Pacino & More
MESA, ARIZONA / ACCESS Newswire / January 7, 2026 / Medical Care Technologies Inc. (OTC Pink:MDCE) is excited to announce that its subsidiary, Infinite Auctions, will host "The Legends Art Auction," an exclusive event showcasing a remarkable collection of original art pieces by renowned artist Rob Prior and others. This highly anticipated auction will feature:
Phase 1 Equity Announces it's First Practice Addition of The Year, Bringing on a Multi-Site Orthodontic Practice Located in Ohio
CHICAGO, IL / ACCESS Newswire / January 7, 2026 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site orthodontic practice based in Ohio to its growing network.
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development
SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced the start of GMP manufacturing of GEMINI and placebo. This manufacturing run will provide the Company with clinical drug supply for later stage clinical studies.
Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)
FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial
Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products
Canadian Patent Enhances Market Exclusivity and Licensing PotentialExpands Global Intellectual Property Portfolio Supporting Long-Term Revenue Growth
Forte Group Confirms Effective Date of Corporate Name Change to VANTA, advancing its Blackwater Ready-to-Drink Platform and Longevity-Focused Nutraceutical Strategy, and Announces Strategic Share Consolidation to Advance Corporate Growth and Capital Markets Presence
News Release Highlights:Forte Group has confirmed the effective date of its previously announced corporate name change to Vanta Holdings Inc. ("VANTA") and approved a strategic 10-for-1 share consolidation, both to take effect at the start of trading on January 13, 2026, advancing the Company's corporate growth strategy and capital markets positioning.The transition to the VANTA identity unifies the Company's Blackwater ready-to-drink platform and longevity-focused nutraceutical portfolio under a single, modernized brand, aligning the parent company and its consumer-facing product ecosystem and supporting scalable commercialization across Canadian, U.S., and international markets.The share consolidation is intended to enhance the marketability of the Company's common shares, improve investor accessibility, and provide flexibility to support future corporate initiatives and financing activities, while aligning the Company's capital structure with its long-term operational and growth objectives.
Wellgistics Health Provides 2026 Corporate Outlook
Integration of prescription drug dispensing optimization aritifical intelligence platform EinsteinRx™ into pharmacy client point-of-sales systems has commencedEinsteinRx integration streamlining effort focuses on reducing onboarding process friction and speeding time to implementation prior to scaling pharmacy marketing effortCompany expects to onboard up to 500 pharmacies per month into formal Wellgistics Pharmacy Network by year end 2026Manufacturer supplier relationship expansion effort focused on diabetes, weight loss, cardiometabolic & Long COVID patients that existing pharmacy clients already servePharmacyChain™ blockchain-enabled healthcare smart contract development resource assessment ongoing
Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026
NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference taking place January 12-15, 2026 in San Francisco, CA. The Company will also participate in one-on-one meetings.
Nepra Foods Appoints Cotter Stern as Director of Ingredient Sales
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 7, 2026 / Nepra Foods Inc. (CSE:NPRA)(FSE:2P6)(OTCQB:NPRFF), a leader in specialty ingredients and allergen-free products, today announced the appointment of Cotter Stern as Director of Ingredient Sales. With over 15 years of experience in organic food trading, Mr. Stern brings deep technical understanding of global commodity markets and a proven track record of building sustainable supply chains. Mr. Stern's esteemed reputation will accelerate Nepra Foods' growth trajectory.